Intervention for Fall Prevention — A Pilot Fall Prevention Program Using "STRATIFY" at Triage of Emergency Department in Hong Kong
Citation(s)
Chu LW, Chiu AY, Chi I Falls and subsequent health service utilization in community-dwelling Chinese older adults. Arch Gerontol Geriatr. 2008 Mar-Apr;46(2):125-35. Epub 2007 Apr 27.
Luk JKH, Chiu PKC, Chu LW Factors affecting institutionalization in older Hong Kong Chinese patients after recovery from acute medical illnesses. Arch Gerontol Geriatr. 2009 Sep-Oct;49(2):e110-e114. doi: 10.1016/j.archger.2008.10.007. Epub 2008 Dec 17.
Oliver D, Papaioannou A, Giangregorio L, Thabane L, Reizgys K, Foster G A systematic review and meta-analysis of studies using the STRATIFY tool for prediction of falls in hospital patients: how well does it work? Age Ageing. 2008 Nov;37(6):621-7. doi: 10.1093/ageing/afn203. Epub 2008 Oct 1. Review.
Phelan EA, Mahoney JE, Voit JC, Stevens JA Assessment and management of fall risk in primary care settings. Med Clin North Am. 2015 Mar;99(2):281-93. doi: 10.1016/j.mcna.2014.11.004. Review.
A Pilot Fall Prevention Program Using "STRATIFY" at Triage of Emergency Department in Hong Kong
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
